Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis

Abroad (travel likely)Recruiting

Conditions

Rifampin-resistant Tuberculosis · Drug-resistant Tuberculosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Nkqubela TB Specialist Hospital, East London, Eastern Cape, South Africa
Contact: Study coordinator (Gary Maartens, MBChB)
Contact: Principal Investigator (Gary Maartens, MBChB)

Study leads

James CM Brust, MD
Principal Investigator
Albert Einstein College of Medicine
Gary Maartens, MBChB
Principal Investigator
University of Cape Town

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets

Tuberculosis · Multidrug Resistant Pulmonary Tuberculosis · Rifampicin-resistant Tuberculosis

Abroad (travel likely)RecruitingPHASE2

Wuhan, China · Changsha, China

Novel Triple-dose Tuberculosis Retreatment Regimen

Multidrug-resistant Tuberculosis · Pulmonary Tuberculosis · Tuberculosis

Abroad (travel likely)RecruitingPHASE3

Niamey, Niger

Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)

Tuberculosis · Multidrug Resistant Tuberculosis

Abroad (travel likely)RecruitingPHASE2

Paris, France

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Tuberculosis, Pulmonary · Tuberculosis, Multidrug-Resistant · Tuberculosis, MDR

Abroad (travel likely)RecruitingPHASE2, PHASE3

Ulaanbaatar, Mongolia · Kotri, Pakistan